STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serve… Read more
STAAR Surgical Company (STAA) - Total Liabilities
Latest total liabilities as of September 2025: $102.58 Million USD
Based on the latest financial reports, STAAR Surgical Company (STAA) has total liabilities worth $102.58 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
STAAR Surgical Company - Total Liabilities Trend (1988–2024)
This chart illustrates how STAAR Surgical Company's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
STAAR Surgical Company Competitors by Total Liabilities
The table below lists competitors of STAAR Surgical Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alerus Financial Corp
NASDAQ:ALRS
|
USA | $4.67 Billion |
|
Eastman Kodak Co
NYSE:KODK
|
USA | $1.21 Billion |
|
Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A
SHG:688221
|
China | CN¥619.25 Million |
|
Universal Health Realty Income Trust
NYSE:UHT
|
USA | $409.46 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €455.26 Million |
|
Xiamen Port Development Co Ltd
SHE:000905
|
China | CN¥6.96 Billion |
|
Odontoprev S.A
SA:ODPV3
|
Brazil | R$958.26 Million |
Liability Composition Analysis (1988–2024)
This chart breaks down STAAR Surgical Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how STAAR Surgical Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for STAAR Surgical Company (1988–2024)
The table below shows the annual total liabilities of STAAR Surgical Company from 1988 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $112.19 Million | +9.20% |
| 2023-12-31 | $102.74 Million | +24.22% |
| 2022-12-31 | $82.71 Million | -5.18% |
| 2021-12-31 | $87.22 Million | +44.90% |
| 2020-12-31 | $60.19 Million | +26.35% |
| 2019-12-31 | $47.64 Million | +36.45% |
| 2018-12-31 | $34.91 Million | +39.67% |
| 2017-12-31 | $25.00 Million | -9.23% |
| 2016-12-31 | $27.54 Million | +14.23% |
| 2015-12-31 | $24.11 Million | +10.53% |
| 2014-12-31 | $21.81 Million | -5.49% |
| 2013-12-31 | $23.08 Million | +0.27% |
| 2012-12-31 | $23.02 Million | +17.75% |
| 2011-12-31 | $19.55 Million | +7.66% |
| 2010-12-31 | $18.16 Million | -51.72% |
| 2009-12-31 | $37.61 Million | +2.89% |
| 2008-12-31 | $36.55 Million | +103.60% |
| 2007-12-31 | $17.95 Million | +12.14% |
| 2006-12-31 | $16.01 Million | +29.23% |
| 2005-12-31 | $12.39 Million | -12.20% |
| 2004-12-31 | $14.11 Million | +19.63% |
| 2003-12-31 | $11.80 Million | -19.03% |
| 2002-12-31 | $14.57 Million | -23.23% |
| 2001-12-31 | $18.98 Million | -11.67% |
| 2000-12-31 | $21.48 Million | -33.07% |
| 1999-12-31 | $32.10 Million | +29.96% |
| 1998-12-31 | $24.70 Million | +40.34% |
| 1997-12-31 | $17.60 Million | +21.38% |
| 1996-12-31 | $14.50 Million | +43.56% |
| 1995-12-31 | $10.10 Million | +46.38% |
| 1994-12-31 | $6.90 Million | +1.47% |
| 1993-12-31 | $6.80 Million | +23.64% |
| 1992-12-31 | $5.50 Million | +7.84% |
| 1991-12-31 | $5.10 Million | -51.43% |
| 1990-12-31 | $10.50 Million | -50.70% |
| 1989-12-31 | $21.30 Million | +5.97% |
| 1988-12-31 | $20.10 Million | -- |